Yangyang Hao

3.1k total citations · 1 hit paper
76 papers, 2.3k citations indexed

About

Yangyang Hao is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yangyang Hao has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Cancer Research and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yangyang Hao's work include Thyroid Cancer Diagnosis and Treatment (16 papers), Cancer-related molecular mechanisms research (11 papers) and RNA modifications and cancer (10 papers). Yangyang Hao is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (16 papers), Cancer-related molecular mechanisms research (11 papers) and RNA modifications and cancer (10 papers). Yangyang Hao collaborates with scholars based in China, United States and Hong Kong. Yangyang Hao's co-authors include Yadong Wang, Qinghua Jiang, Mingxiang Teng, Guoxiu Wang, Juan Li, Yaohua Liu, Yunlong Liu, Tianjiao Zhang, Guohua Wang and Liran Juan and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yangyang Hao

68 papers receiving 2.3k citations

Hit Papers

miR2Disease: a manually curated database for microRNA der... 2008 2026 2014 2020 2008 250 500 750 1000

Peers

Yangyang Hao
Mei Yang China
Cheng Ji China
In‐Hee Lee South Korea
Young Kim South Korea
Mayank Tandon United States
Mei Yang China
Yangyang Hao
Citations per year, relative to Yangyang Hao Yangyang Hao (= 1×) peers Mei Yang

Countries citing papers authored by Yangyang Hao

Since Specialization
Citations

This map shows the geographic impact of Yangyang Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyang Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyang Hao more than expected).

Fields of papers citing papers by Yangyang Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyang Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyang Hao. The network helps show where Yangyang Hao may publish in the future.

Co-authorship network of co-authors of Yangyang Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyang Hao. A scholar is included among the top collaborators of Yangyang Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyang Hao. Yangyang Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antonarakis, Emmanuel S., Mohammed Alshalalfa, Benjamin A. Teply, et al.. (2025). Assessment of PARP1 mRNA expression as prognostic of aggressive pathology and adverse outcomes, and as predictor of response to PARP inhibition in castration-sensitive prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 202–202. 2 indexed citations
2.
Hao, Yangyang, Mohammed Alshalalfa, J. Proudfoot, et al.. (2025). Tumor necrosis factor alpha signaling activity and NCCN risk, adverse pathology, and progression during active surveillance in prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 415–415. 1 indexed citations
3.
Krossa, Sebastian, Maria Andersen, Maximilian Wess, et al.. (2025). Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment. Nature Communications. 16(1). 10160–10160.
4.
Ma, Yanan, Qun Wang, Yanxi Li, et al.. (2025). Selection and characterization of novel DNA aptamers targeting colorectal cancer cells with malignant potential. Analytical and Bioanalytical Chemistry. 417(26). 5941–5955.
5.
Li, Eric V., J. Proudfoot, Adam B. Weiner, et al.. (2025). Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate Cancer. European Urology Oncology. 8(4). 1050–1058. 1 indexed citations
6.
Rao, Jianhua, Chao Song, Yangyang Hao, et al.. (2024). Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment. International Journal of Biological Sciences. 20(13). 5363–5374. 6 indexed citations
7.
Jasim, Sina, David N. Bimston, Mohammed Alshalalfa, et al.. (2024). Cytologic and Molecular Assessment of Isthmus Thyroid Nodules and Carcinomas. Thyroid. 35(3). 255–264. 1 indexed citations
8.
Guo, Hongliang, Yangyang Hao, & Jie Wang. (2023). Warehouse AGV path planning based on Improved A* algorithm. 57. 61–61. 1 indexed citations
9.
Livhits, Masha J., Michael W. Yeh, Joshua Klopper, et al.. (2023). Histopathology of telomerase reverse transcriptase promoter (TERT) mutated indeterminate thyroid nodules. Journal of Clinical & Translational Endocrinology. 35. 100329–100329. 2 indexed citations
10.
Ladenson, Paul W., Joshua Klopper, Yangyang Hao, et al.. (2023). Combined Afirma Genomic Sequencing Classifier and TERT promoter mutation detection in molecular assessment of Bethesda III–VI thyroid nodules. Cancer Cytopathology. 131(10). 609–613. 2 indexed citations
11.
Phay, John E., Shelby Holt, Yangyang Hao, et al.. (2022). Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations. Frontiers in Endocrinology. 13. 1073592–1073592. 4 indexed citations
12.
Hu, Mimi I., Steven G. Waguespack, Chrysoula Dosiou, et al.. (2021). Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 106(8). 2198–2207. 40 indexed citations
13.
Wang, Peng, Qiuyan Guo, Yangyang Hao, et al.. (2020). LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution. Nucleic Acids Research. 49(D1). D125–D133. 52 indexed citations
14.
Zhao, Hongmei, Hong-di He, Jane W. Z. Lu, & Yangyang Hao. (2020). Characterizing the variation of particles in varied sizes from a container truck in a port area. Environmental Monitoring and Assessment. 192(12). 787–787. 4 indexed citations
15.
Hao, Yangyang, Liangyu Zhang, Xiang Wang, et al.. (2017). Effects of camptothecin on the autophagy of HaCaT cells. Chinese Journal of Dermatology. 50(2). 86–90.
16.
Wang, Qin, Yan Yan, Linlin Sun, et al.. (2016). Knockdown of microRNA-195 contributes to protein phosphatase-2A inactivation in rats with chronic brain hypoperfusion. Neurobiology of Aging. 45. 76–87. 28 indexed citations
17.
Hao, Yangyang, Pengyue Zhang, Xiaoling Xuei, et al.. (2016). Statistical modeling for sensitive detection of low-frequency single nucleotide variants. BMC Genomics. 17(S7). 514–514. 4 indexed citations
18.
Wang, Min, et al.. (2013). Protein interaction and microRNA network analysis in osteoarthritis meniscal cells. Genetics and Molecular Research. 12(1). 738–746. 11 indexed citations
19.
Jiang, Qinghua, Yangyang Hao, Guohua Wang, et al.. (2010). Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Systems Biology. 4(S1). S2–S2. 335 indexed citations
20.
Jiang, Qinghua, Yadong Wang, Yangyang Hao, et al.. (2008). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Research. 37(Database). D98–D104. 1130 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026